Drugstore Blog News

The American Academy of Allergy, Asthma & Immunology (AAAAI) and CSL Behring are pleased to blazon Duane Wesemann, MD, PhD, of Brigham and Women’s Hospital, as the recipient of the 2010 Young Investigator Award.

The collaborative judgment, funded by an unrestricted grant from CSL Behring and administered by the AAAAI, provides $85,000 by means of year towards three years.

The award supports the development of academic and/or clinical immunology research careers of junior faculty who own demonstrated a commitment to the scrutinize and care of patients by primary immune lack disease. Dr. Wesemann was selected for his study investigating wherefore clear as day immune deficiencies are associated with occult IgE levels.

“Supporting the nearest generation of allergist/immunologists is critical to ensure the subsequent time of the specialty and optimal care in opposition to our patients with radical immune deficiency. This award inclination ensure that Dr. Wesemann has the necessary time and resource support to pursue examination into the immunology of host defenses and abnormalities of the immune combination of parts to form a whole. The AAAAI is pleased to believe a grant from CSL Behring to fund this award,” aforesaid AAAAI President Mark Ballow, MD, FAAAAI.

“CSL Behring is supercilious to collaborate with the AAAAI on developing the Young Investigator Award and congratulates Dr. Wesemann on heart the receiver. CSL Behring and the AAAAI share a mission to advance the world’s understanding of aboriginal immune error with equal reason that people who face this rare and serious case can benefit and enjoy an enhanced quality of life,” uttered Garrett E. Bergman, MD, Senior Director of Medical Affairs, North America Commercial Operations at CSL Behring. “We look impertinent to it being so the results of Dr. Wesemann’s exciting new inquiry made possible by this determination.”

Dr. Wesemann completed his PhD at the Department of Cell Biology, University of Alabama at Birmingham (UAB). He also received his MD of the same kind with lot of the Medical Scientist Training Program at UAB. In the short time between medical school and residency, he completed six months of post-doctoral training through Dr. Max Cooper at UAB, where he was introduced to B cell biology. This introduction to the investigation of B cell biology led to his conclusion to carry at a loss his examination with Fred Alt, PhD, while he obtained his training in Allergy/Immunology in the Division of Rheumatology, Immunology and Allergy of the Department of Medicine at the Brigham and Women’s Hospital.

Dr. Wesemann is currently an Instructor of Medicine at Harvard Medical School. His research on IgE in primary immune deficiency decree have existence conducted at the Immune Disease Institute/Program in Molecular and Cellular Biology at Children’sitting Hospital of Boston.

Source:
AAAAI
CSL Behring

Comments are closed.